Skip to content

Clinical trials

Phase 2 Skin Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Diseases Phase: Phase 2 Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20063
20082
20091
20103
20113
20123
20134
20151
20165
20175
20186
20194
20205
20217
202212
20235
20244
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Active, not recruiting7
Recruiting7
Terminated7
Not yet recruiting4
Unknown status2
Suspended1
Withdrawn1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation6
Novartis Pharmaceuticals5
Pfizer4
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
National Center for Research Resources (NCRR)3
Akros Pharma Inc.2
Amgen2
Apollo Therapeutics Ltd2
Caliway Biopharmaceuticals Co., Ltd.2
Dermata Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Diseases95
Dermatitis, Atopic20
Eczema17
Psoriasis17
Dermatitis16
Immune System Diseases11
Hidradenitis Suppurativa9
Autoimmune Diseases7
Connective Tissue Diseases7
Scleroderma, Diffuse7

Trials

Showing 51 to 75 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.